Latest Temozolomide Stories
Glioblastoma multiforme (GBM) is the most common and lethal of all human brain tumors that originate in the brain.
New research suggests brain tumor patients who take the seizure drug valproic acid on top of standard treatment may live longer than people who take other kinds of epilepsy medications to control seizures.
SEATTLE, Aug. 18, 2011 /PRNewswire/ -- Cell Therapeutics, Inc.
Cleveland Clinic researchers have identified a cellular pathway that cancer stem cells use to promote tumor growth in malignant glioma, an aggressive brain tumor.
An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly diagnosed patients.
SAN DIEGO, June 7, 2011 /PRNewswire/ -- Tocagen Inc.
CHICAGO, June 6, 2011 /PRNewswire/ -- Cell Therapeutics, Inc.
Survival rates of wealthier patients and those younger than 70 with glioblastoma, the most common and aggressive malignant brain tumor, have improved since 2000, whereas rates for those living in poorer areas and older than 70 have remained stagnant.
- Withering but not falling off, as a blossom that persists on a twig after flowering.